73252-56-9

Usage

InChI:InChI=1/C16H22BrNO3/c1-19-13-9-11(10-18-12-7-5-4-6-8-12)14(17)16(21-3)15(13)20-2/h9-10,12H,4-8H2,1-3H3/b18-10+

Upstream product

• 35274-53-4 2-bromo-3,4,5-tri-methoxybenzaldehyde 
• 108-91-8 cyclohexylamine 
• 86-81-7 3,4,5-trimethoxy-benzaldehyde 

Downstream Products

• 894762-68-6 4'-benzyloxy-2'-[1,1-(ethylenedioxy)ethyl]-4,5,6-trimethoxy-biphenyl-2-carbaldehyde 
• 894797-89-8 2'-acetyl-4'-benzyloxy-4,5,6-trimethoxybiphenyl-2-carbaldehyde 
• 894762-73-3 3-benzyloxy-9,10,11-trimethoxy-dibenzo[a,c]cyclohepten-5-one 
• 61599-76-6 4,5-methylenedioxy-4',5',6'-trimethoxy-1,1'-biphenyl-2,2'-dicarboxaldehyde 

Relevant academic research and scientific papers

Asymmetric synthesis of (S)-(-)-N-acetylcolchinol via Ullmann biaryl coupling

A modified Ziegler Ullmann coupling process has been developed as the key step in an effective synthesis of (S)-(-)-N-acetylcolchinol, analogues of which are selective vascular targeting agents with potential importance in cancer chemotherapy. Asymmetric induction is achieved by enamide hydrogenation using FerroTANE catalysts.